ArticleFrontiers in medicine2026
FAD-YOLO: a lightweight feature-refined and task-aligned framework for AIS-MIA discrimination on pulmonary CT.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adenocarcinoma Methods: Using YOLO12n as the baseline, we propose FAD-YOLO (Feature-refinement, Alignment, and Dynamic-sampling YOLO), a lightweight yet accurate detection framework with three task-oriented improvements: an A2C2f-FRFN module that replaces the standard feed-forward network within the Area-Attention C2f module with a Feature Refinement Feed-forward Network; a DySample dynamic upsampling module that replaces nearest-neighbor interpolation with content-aware learnable offsets; and a TADDH task-aligned dynamic detection head that combines a shared group-normalized convolution, deformable sampling in the localization branch, and layer-attention reweighting to alleviate classification-localization misalignment. Results: On an independent internal test set of 317 images, FAD-YOLO achieved a precision of 93.8%, a recall of 93.4%, an mAP@50 of 93.6%, and an mAP@50-95 of 70.8%, while reducing parameters by 18.7% relative to the baseline at the cost of a 12.5% increase in GFLOPs (from 6.4 to 7.2). Under identical settings, it performed comparably to or better than YOLOv5n, YOLOv8n, YOLO11n, and RT-DETR-R18, and outperformed the much larger RT-DETR-R50 on all accuracy metrics despite using approximately one-twentieth of its parameters. On an external Mendeley Data test set, the model achieved mAP@50 = 91.7% and mAP@50-95 = 68.2% without any fine-tuning. Discussion: FAD-YOLO achieves a favorable balance among accuracy, lightweight design, and cross-dataset generalization, and may serve as a candidate for further prospective validation as an aid to radiologists in AIS/MIA discrimination on resource-constrained clinical devices.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.